Related Experiment Videos
Transitional cell carcinoma in an ileal conduit
T K Rosvanis1, T J Rohner, A B Abt
1Division of Urology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Cancer
|March 15, 1989
Summary
Recurrent transitional cell carcinoma can occur synchronously at the ureteroileal anastomosis and renal pelvis after bladder cancer treatment. Hematuria is a key presenting symptom in patients with ileal conduit cancer.
Area of Science:
- Uro-oncology
- Surgical pathology
Background:
- Transitional cell carcinoma (TCC) of the urinary bladder is a significant clinical challenge.
- Urinary diversion, such as ileal conduit, is a common treatment for invasive bladder cancer.
- Recurrence of TCC after treatment requires careful monitoring and diagnosis.
Observation:
- A 73-year-old male patient presented with synchronous recurrent TCC.
- Recurrence occurred at the ureteroileal anastomosis and the right renal pelvis.
- Hematuria was the primary presenting symptom, consistent with prior reports.
Findings:
- The case highlights synchronous TCC recurrence in distinct urinary tract segments post-diversion.
- Pathologic examination confirmed the nature and location of the recurrent tumors.
- Diagnostic modalities and treatment strategies for such recurrences are critical.
Implications:
- Early detection of synchronous TCC recurrence is crucial for effective management.
- Understanding recurrence patterns aids in developing surveillance protocols for bladder cancer survivors.
- This case underscores the importance of vigilant follow-up in patients with a history of TCC and ileal conduits.